CRMD · CorMedix Inc. · Executive Compensation
$7.57
+0.19 (+2.57%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$590.04M
Shares
77.94M
Volume · Oct 20
971.66K
Avg daily vol (3M)
1.12M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Joseph Todisco | Chief Executive Officer | $6,101,176 |
| Beth Zelnick Kaufman | Executive Vice President, Chief Legal/Compliance Officer & Corp. Secretary | $3,765,910 |
| Elizabeth Hurlburt | Executive Vice President, Chief Operating Officer | $3,743,688 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Joseph Todisco | Chief Executive Officer | $2,359,908 |
| Elizabeth Hurlburt | Executive Vice President, Chief Clinical Strategy and Operations Officer | $1,135,365 |
| Matthew David | Chief Financial Officer | $1,088,025 |
| Beth Zelnick Kaufman | Executive Vice President, Chief Legal/Compliance Officer & Corp. Secretary | $714,352 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Joseph Todisco | Chief Executive Officer | $2,459,342 |
| Phoebe Mounts | Former Executive Vice President and General Counsel and Head of Regulatory, Compliance and Legal | $1,254,582 |
| Erin Mistry | Executive Vice President and Chief Commercial Officer | $1,240,577 |
| Matthew David | Chief Financial Officer | $1,031,150 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Joseph Todisco | Chief Executive Officer | $2,691,189 |
| Matthew David | Chief Financial Officer | $1,136,544 |
| Phoebe Mounts | Former Executive Vice President and General Counsel and Head of Regulatory, Compliance and Legal | $1,010,481 |
| Thomas Nusbickel | Former Chief Commercial Officer | $945,877 |
| Elizabeth Hurlburt | Executive Vice President and Head of Clinical Operations | $844,811 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Khoso Baluch | Former Chief Executive Officer | $2,596,173 |
| Thomas Nusbickel | Former Chief Commercial Officer | $1,876,582 |
| Phoebe Mounts | Executive Vice President and General Counsel and Head of Regulatory, Compliance and Legal | $1,613,097 |
| Matthew David | Executive Vice President and Chief Financial Officer | $1,423,302 |
| John Armstrong | Former Executive Vice President for Technical Operations | $1,339,348 |
| Elizabeth Hurlburt | Executive Vice President and Head of Clinical Operations | $1,136,328 |
| Elizabeth Masson-Hurlburt | Executive Vice President and Head of Clinical Operations | $1,136,328 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Khoso Baluch | Former Chief Executive Officer | $1,233,671 |
| Matthew David | Executive Vice President and Chief Financial Officer | $1,097,675 |
| Phoebe Mounts | Executive Vice President and General Counsel and Head of Regulatory, Compliance, Legal and Technical Operations | $931,148 |
| Elizabeth Masson-Hurlburt | Executive Vice President and Head of Clinical Operations | $796,273 |
| John Armstrong | Former Executive Vice President for Technical Operations | $787,318 |
| Robert W. Cook | Chief Financial Officer | $245,018 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Khoso Baluch | Chief Executive Officer | $1,795,829 |
| Phoebe Mounts | Executive Vice President and General Counsel and Head of Regulatory, Compliance and Legal | $746,154 |
| Elizabeth Masson-Hurlburt | Executive Vice President and Head of Clinical Operations | $671,438 |
| John Armstrong | Executive Vice President for Technical Operations | $464,996 |
| Matthew David | Chief Financial Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Joseph Todisco | Chairman of the Company's board of directors | Appointed | 2026-01-08 |
| Beth Zelnick Kaufman | EVP & Chief Legal and Compliance Officer and Corporate Secretary | Appointed | 2025-09-02 |
| Beth Steinbrenner | SVP and Chief Human Resource Officer | Appointed | 2025-09-02 |
| Liz Hurlburt | EVP & Chief Operating Officer | Appointed | 2025-09-02 |
| Dr. Matt David | EVP & Chief Business Officer | Appointed | 2025-09-02 |
| Matt David | Executive Vice President and Chief Business Officer | Appointed | 2025-09-02 |
| Susan Blum | Executive Vice President and Chief Financial Officer | Appointed | 2025-09-02 |
| Matthew David | Chief Business Officer | Appointed | 2025-09-02 |
| Elizabeth Hurlburt | Chief Operating Officer | Appointed | 2025-09-02 |
| Susan Blum | Chief Financial Officer | Appointed | 2025-09-02 |
| Phoebe Mounts | Executive Vice President | Terminated | 2023-12-15 |
| Phoebe Mounts | General Counsel and Corporate Secretary | Terminated | 2023-12-15 |
| Paulo F. Costa | member of the Board of Directors | Retired | 2023-08-17 |
| Robert Stewart | director | Appointed | 2023-04-17 |
Leadership
- Joseph Todisco CEO, Chairman, Board Member
- Matt David, M.D. CEO
- Robert W. Cook CFO
- Susan Blum CFO
- Elizabeth Hurlburt COO
- Liz Hurlburt COO
- Beth Zelnick Kaufman General Counsel
- Alan W. Dunton Board Member
- Gregory Duncan Board Member
- Janet Dillione Board Member
- Myron Kaplan Board Member
- Robert Stewart Board Member
- Steven Lefkowitz Board Member
Key facts
CIK
1410098
CUSIP
21900C308
13F (30d)
13 filings
13 filers
Visit website
Investor relations